-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, C4YpAqLPDxAB873TAb+bV0xM5pfqCR1hp7++sBr77M/EYMKw54uWw2x7h3djxylc m7M1bNSnQz9JHf1vh50kaQ== 0001225208-10-022519.txt : 20101008 0001225208-10-022519.hdr.sgml : 20101008 20101008161633 ACCESSION NUMBER: 0001225208-10-022519 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20101006 FILED AS OF DATE: 20101008 DATE AS OF CHANGE: 20101008 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE BOSTON SCIENTIFIC PL CITY: NATICK STATE: MA ZIP: 01760-1537 BUSINESS PHONE: 5086508000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NICHOLAS PETER M CENTRAL INDEX KEY: 0000901458 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11083 FILM NUMBER: 101116294 MAIL ADDRESS: STREET 1: C/O BOSTON SCIENTIFIC CORPORATION STREET 2: ONE BOSTON SCIENTIFIC PLACE CITY: NATICK STATE: MA ZIP: 01760-1537 4 1 doc4.xml X0303 4 2010-10-06 0000885725 BOSTON SCIENTIFIC CORP BSX 0000901458 NICHOLAS PETER M ONE BOSTON SCIENTIFIC PLACE NATICK MA 01760-1537 1 Common Stock 2010-10-06 4 S 0 25000.0000 6.1223 D 5131021.0000 I By Ltd. Partnership Common Stock 2010-10-06 4 J 0 50000.0000 0.0000 D 5081021.0000 I By Ltd. Partnership Common Stock 9212125.0000 D Common Stock 2413088.0000 I By Trust 2 Forward Sale Contract (obligation to sell) 2010-10-06 4 J 0 50000.0000 0.0000 D 2010-10-06 2010-10-06 Common Stock 50000.0000 0.0000 I By Ltd. Partnership Sales reported on this form were transacted pursuant to a 10b5-1 trading plan. Weighted average sales price reported as stock sales were aggregated for reporting purposes. The per share transaction price ranged from $6.1602 to $6.11. The reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices. On August 26, 2009, a family limited partnership of which the reporting person is a general and limited partner, Promerica LP, entered into a Rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. On October 6, 2010, Promerica settled a prepaid variable contract originally entered into on October 6, 2009. At the initiation of the contract, the bank paid $397,136.69 to the reporting person. The forward sale contract obligated Promerica to deliver to the bank at maturity up to 50,000 shares of the Issuer's common stock depending on market prices at maturity. If the market price per share at maturity was equal to or less than the floor price of $9.9086 per share, Promerica would deliver 50,000 shares to the bank. If the market price per share at maturity was greater than the floor price, Promerica would deliver a fewer number of shares. The closing market price per share on October 6, 2010 was $6.14. Accordingly, Promerica transferred to the bank 50,000 shares of the Issuer's common stock. Shares held by a trust of which the reporting persons spouse and brother are trustees and the reporting person's spouse and children are beneficiaries. /s/ Michelle K. Gewandter Attorney-in-Fact 2010-10-08 -----END PRIVACY-ENHANCED MESSAGE-----